Patent · US Active

Therapeutic compounds and uses thereof

US10358437B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignees

Genentech, Inc. · US
Constellation Pharmaceuticals, Inc. · US

Inventors

Brian K. Albrecht · Cambridge, US
Alexandre Cote · Cambridge, US
Terry Crawford · San Mateo, US
Martin Duplessis · Somerville, US
Andrew C. Good · Wallingford, US
Yves LeBlanc · Toronto, CA
Steven R. Magnuson · South San Francisco, US
Christopher G. Nasveschuk · Stoneham, US
Richard Pastor · South San Francisco, US
F. Anthony Romero · South San Francisco, US
Alexander M. Taylor · Cambridge, US

Key dates

Filing date	Mar 3, 2017
Grant date	Jul 23, 2019
Priority date	—
Expiry date	Mar 3, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating PCAF mediated disorders using a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1, R3-R6, X, and each Re have any of the values defined in the specification. Also included are novel compounds of formula (I) and salts thereof, as well as pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.